New Vaccibody publication
82
post-template-default,single,single-post,postid-82,single-format-standard,bridge-core-1.0.4,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-18.2.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

New Vaccibody publication

The newly published paper by Gunnveig Grodeland et al: DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza, describes the vaccibody platform as a robust and effective vaccine for prophylactic use. The paper can be downloaded here